Lido Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Lido Advisors, LLC

  • $20.3 Billion
  • Q3 2024

A detailed history of Lido Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Lido Advisors, LLC holds 2,113 shares of REGN stock, worth $1.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,113
Previous 1,935 9.2%
Holding current value
$1.65 Million
Previous $2.03 Million 9.25%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $182,288 - $213,913
178 Added 9.2%
2,113 $2.22 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $68,006 - $82,481
77 Added 4.14%
1,935 $2.03 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $160,678 - $176,816
178 Added 10.6%
1,858 $1.79 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $177,516 - $201,909
229 Added 15.78%
1,680 $1.48 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $455,632 - $555,595
-658 Reduced 31.2%
1,451 $1.19 Million
Q2 2023

Aug 09, 2023
BUY
$700.03 - $830.35 $486,520 - $577,093
695 Added 49.15%
2,109 $1.52 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $419,181 - $509,413
616 Added 77.19%
1,414 $1.16 Million
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $108,001 - $117,257
153 Added 23.72%
798 $575,000
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $6,887 - $8,691
-12 Reduced 1.83%
645 $444,000
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $123,927 - $166,977
-226 Reduced 25.59%
657 $388,000
Q1 2022

May 17, 2022
BUY
$595.12 - $698.43 $135,687 - $159,242
228 Added 34.81%
883 $616,000
Q4 2021

Feb 15, 2022
SELL
$543.48 - $670.97 $46,739 - $57,703
-86 Reduced 11.61%
655 $413,000
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $63,143 - $74,905
110 Added 17.43%
741 $449,000
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $155,551 - $183,759
-329 Reduced 34.27%
631 $353,000
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $183,606 - $225,310
411 Added 74.86%
960 $455,000
Q4 2020

Feb 08, 2021
SELL
$478.3 - $607.98 $44,481 - $56,542
-93 Reduced 14.49%
549 $265,000
Q3 2020

Nov 12, 2020
BUY
$544.75 - $658.21 $128,016 - $154,679
235 Added 57.74%
642 $359,000
Q2 2020

Aug 12, 2020
SELL
$493.32 - $643.92 $237,780 - $310,369
-482 Reduced 54.22%
407 $254,000
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $3,295 - $4,563
11 Added 1.25%
889 $278,000
Q1 2019

May 10, 2019
SELL
$372.08 - $439.57 $4,092 - $4,835
-11 Reduced 1.24%
878 $360,000
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $298,543 - $358,302
889 New
889 $332,000

Others Institutions Holding REGN

# of Institutions
1,524
Shares Held
84M
Call Options Held
1.14M
Put Options Held
1.48M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $83.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email